Apollon Wealth Management, LLC Eli Lilly & CO Transaction History

Apollon Wealth Management, LLC

$5.29 Billion
Q3 2025

A detailed history of Apollon Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Apollon Wealth Management, LLC holds 42,686 shares of LLY stock, worth $36.8 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

42,686

Previous 38,388 11.2%

Holding current value

$36.8 Million

Previous $29.9 Million 8.84%

% of portfolio

0.62%

Previous 0.62%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 16, 2025	BUY	$625.65 - $812.69 $2.69 Million - $3.49 Million	4,298 Added 11.2%	42,686 $32.6 Million
Q2 2025 Jul 24, 2025	BUY	$713.71 - $898.95 $3.05 Million - $3.84 Million	4,271 Added 12.52%	38,388 $29.9 Million
Q1 2025 May 01, 2025	BUY	$725.72 - $929.72 $10.5 Million - $13.4 Million	14,466 Added 73.61%	34,117 $28.2 Million
Q4 2024 Jan 28, 2025	BUY	$727.2 - $932.06 $3.94 Million - $5.05 Million	5,421 Added 38.1%	19,651 $15.2 Million
Q3 2024 Nov 04, 2024	BUY	$772.14 - $960.02 $722,723 - $898,578	936 Added 7.04%	14,230 $12.6 Million
Q2 2024 Jul 19, 2024	BUY	$724.87 - $909.04 $267,477 - $335,435	369 Added 2.85%	13,294 $12 Million
Q1 2024 May 02, 2024	SELL	$592.2 - $792.28 $446,518 - $597,379	-754 Reduced 5.51%	12,925 $10.1 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $2.42 Million - $2.85 Million	4,609 Added 50.82%	13,679 $7.97 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $736,381 - $1.02 Million	-1,694 Reduced 15.74%	9,070 $4.87 Million
Q2 2023 Aug 04, 2023	BUY	$350.74 - $468.98 $919,991 - $1.23 Million	2,623 Added 32.22%	10,764 $5.05 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $236,700 - $277,992	762 Added 10.33%	8,141 $2.8 Million
Q4 2022 Feb 15, 2023	BUY	$321.55 - $374.67 $34,405 - $40,089	107 Added 1.47%	7,379 $2.7 Million
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $160,395 - $182,787	541 Added 8.04%	7,272 $2.35 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $122,919 - $144,326	441 Added 7.01%	6,731 $2.18 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $338,892 - $421,157	1,444 Added 29.8%	6,290 $1.8 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $528,397 - $655,744	2,350 Added 94.15%	4,846 $1.34 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $312,456 - $384,521	1,410 Added 129.83%	2,496 $577,000
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $155,995 - $201,778	-864 Reduced 44.31%	1,086 $249,000
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $320,424 - $414,804	1,950 New	1,950 $364,000
Q3 2020 Nov 03, 2020	SELL	$146.22 - $169.13 $31,144 - $36,024	-213 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $29,057 - $34,970	213 New	213 $35,000

Others Institutions Holding LLY

# of Institutions

4,470

Shares Held

779M

Call Options Held

16.9M

Put Options Held

12.6M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $820B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Wealth Management, LLC with notifications on news.

Account

Apollon Wealth Management, LLC Eli Lilly & CO Transaction History